atrial fib in rheumatic dz: warfarin better than rivaroxaban
Another article on atrial fibrillation (AF) was just published, finding that warfarin was superior to rivaroxaban in those with rheumatic heart disease (see afib warf better than rivarox in RHD NEJM2022 in dropbox or DOI: 10.1056/NEJMoa2209051) Details: -- 4531 patients with atrial fibrillation or atrial flutter and echocardiographically documented rheumatic heart disease who had any of: -- CHA 2 DS 2 VASc score of at least 2 -- or echocardiographic mitral-valve area of no more than 2 cm 2 , left atrial spontaneous echo contrast, or left atrial thrombus -- mean age of the patients was 51 years, 72% were women, BMI 24.5 -- eGFR 81, heart failure 39%, hypertension 23% (mean SBP 116 mmHg), stroke 11% -- CHA 2 DS 2 VASc score 1.9 -- patients were from Africa, Asia, and Latin Amercia -- those who were included in the study were because of: mitral stenosis in 82%, CHA 2 DS 2 VASc score i...